Buscar
01/11/2025
[Translated article] Development of the mobile application Guide to medication reconciliation in the critically ill patient
Cerezuelaa, MM, Morenob, FB, Ramosc, JR, Pintod, AD, Chivae, ED, Rubiof, MV, Gonzálezg, IA, Fernándezh, CB, Morali, LD, Lugeaj, AE, Garciak, MAA, Garcial, TB, Sacristánm, SC, Fernándezh, MA, Pérezn, SO, Tomáso, LPD. [Translated article] Development of the mobile application Guide to medication reconciliation in the critically ill patient. Farmacia Hospitalaria. 2025; 49(6)DOI:10.1016/j.farma.2025.06.007. PMID:40681428. IF:(Q/D).
11/10/2025
Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence
Muñoz-Carrillo, FJ, Reyes, RM, Pesántez, D, Carrera, G, Cascos, E, Castro, P, Fernández-Méndez, S, Font, C, González-Aguado, L, Grafiá, I, Llavata, L, Monge-Escartín, I, Padrosa, J, Reguart, N, Téllez, A, Tuca, A, Viladot, M, Zamora-Martínez, C, Amorós-Reboredo, P, Marco-Hernández, J. Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence. Current Oncology. 2025; 32(10)DOI:10.3390/curroncol32100568. PMID:41149488. IF:3.400(Q2/4D).
01/10/2025
Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation
Redondo, S, García-Cadenas, I, Esquirol, A, Iranzo, E, Arguello-Tomas, M, Saavedra, S, Oñate, G, Caballero, AC, Garrido, A, López, J, Muntañola, A, Paviglianiti, A, Portos, JM, Moreno-Martinez, ME, Riba, M, Sierra, J, Briones, J, Martino, R. Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 115(4)DOI:10.1111/ejh.70010. PMID:40697075. IF:2.300(Q2/5D).
01/10/2025
Sex and gender differences in cancer pathogenesis and pharmacology
Bernardez, B, Higuera, O, Martinez-Callejo, V, Cardeña-Gutiérrez, A, Rodríguez, JAM, Bertrán, AS, Majem, M, Moreno-Martínez, ME. Sex and gender differences in cancer pathogenesis and pharmacology. Clinical & Translational Oncology. 2025; 27(10)DOI:10.1007/s12094-025-03894-1. PMID:40164824. IF:2.500(Q3/6D).
01/10/2025
Comparison of antimicrobial consumption indicators in the emergency department
Ruiz-Ramos, J, Monje-López, AE, Escolà-Vergé, L, Herrera-Mateo, S, Hernández-Ontiveros, H, Duch-Llorach, P, Fernández-de-Gamara-Martinez, E, Rivera-Martinez, MA, Pereira-Batista, CS, López-Contreras, J. Comparison of antimicrobial consumption indicators in the emergency department. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2025; 43(8)DOI:10.1016/j.eimc.2025.01.009. PMID:. IF:2.500(Q2/5D).
29/09/2025
Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study
Plaza-Díaz, A, Juanes-Borrego, A, Sanz-Lopez, N, González-Bueno, J, Fernández-Morató, J, García-Peláez, M, Ruiz-Ramos, J. Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study. Journal of Clinical Medicine. 2025; 14(19)DOI:10.3390/jcm14196907. PMID:41095987. IF:2.900(Q1/2D).
01/09/2025
Map of the residency rotations for hospital pharmacy internal resident in Spain
Aguilar, CC, Negro-Vega, E, de Gamarra-Martinez, EF, Castro, BM, Abánades, MP, Capafons, SR, Conde, CPM. Map of the residency rotations for hospital pharmacy internal resident in Spain. Farmacia Hospitalaria. 2025; 49(5)DOI:10.1016/j.farma.2025.03.014. PMID:40348652. IF:(Q/D).
01/09/2025
Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain
Marin, JM, Molina-Olano, M, Sola, NR, Miserachs-Aranda, N, Alcón, PM, De Pourcq, JT, Ribas, CQ, Trias, LB, Fernández-Cañabate, E, González-Valdivieso, J, Figueiredo-Escribá, C, Delgado-Hernández, R, Braza, AJ, Lastra, CF, Mariño, EL, Modamio, P. Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain. CLINICAL RHEUMATOLOGY. 2025; 44(9)DOI:10.1007/s10067-025-07568-9. PMID:40707848. IF:2.800(Q2/5D).
01/09/2025
Sex-related differences in the efficacy and toxicity of cancer treatments
Bertrán, AS, Rodríguez, JAM, Cardeña-Gutiérrez, A, Martinez-Callejo, V, Higuera, O, Bernardez, B, Moreno-Martínez, ME, Majem, M. Sex-related differences in the efficacy and toxicity of cancer treatments. Clinical & Translational Oncology. 2025; 27(9)DOI:10.1007/s12094-025-03893-2. PMID:40153220. IF:2.500(Q3/6D).
26/08/2025
Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
Anguera, G, Gallego, O, Llobet, M, Berga, N, Moreno-Martinez, ME, Leon, X, Kratz, C, Garcia-Escudero, R, Minguillón, J, Surrallés, J. Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma. BMC CANCER. 2025; 25(1)DOI:10.1186/s12885-025-14619-6. PMID:40859225. IF:3.400(Q2/4D).
18/08/2025
Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance
Ruiz-Ramos, J. Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance. Antibiotics-Basel. 2025; 14(8)DOI:10.3390/antibiotics14080835. PMID:40868029. IF:4.600(Q1/2D).
08/08/2025
The Role of Pharmacogenetic Biomarkers in Pain
da Silva, IM, Plaza-Díaz, A, Ruiz-Ramos, J, Juanes-Borrego, A, Riera, P. The Role of Pharmacogenetic Biomarkers in Pain. Biomedicines. 2025; 13(8)DOI:10.3390/biomedicines13081935. PMID:40868188. IF:3.900(Q1/3D).
01/07/2025
Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to ß-blockers: A double-blind, placebo-controlled, randomized trial
Alvarado-Tapias, E, Brujats, A, Puente, A, Ardevol, A, Rodriguez-Arias, A, Fajardo, J, Pavel, O, Garcia-Guix, M, Aracil, C, Poca, M, Cuyàs, B, Cantó, E, Montañés, R, Garcia-Osuna, A, Escorsell, A, Torras, X, Villanueva, C. Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to ß-blockers: A double-blind, placebo-controlled, randomized trial. HEPATOLOGY. 2025; 82(1)DOI:10.1097/HEP.0000000000001148. PMID:39509369. IF:15.800(Q1/1D).
01/07/2025
Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital
Duch-Llorach, P, Simonetti, AF, Figueras-Roig, A, Rivera, A, de Gamarra-Martínez, EF, Gras-Martin, L, Moreno-Martinez, ME, Ramos, JR, Zarate-Tamames, B, Navarro, F, López-Contreras, J, Escolà-Vergé, L. Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital. JOURNAL OF HOSPITAL INFECTION. 2025; 161DOI:10.1016/j.jhin.2025.04.016. PMID:40306370. IF:3.100(Q1/3D).
01/05/2025
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy
Colominas-Gonzalez, E, De Antonio, M, Masip, M, Conde, MTM, Cardona, G, Restituto, DF, Comas, D, Roch, MA, Lopez, B, Torres-Bondia, FI, Retamero, A, Knobel, H, Luque, S. Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2025; 32(3)DOI:10.1136/ejhpharm-2024-004118. PMID:38802166. IF:1.500(Q4/8D).
17/04/2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma
Caballero, AC, Ujaldón-Miró, C, Pujol-Fernández, P, Montserrat-Torres, R, Guardiola-Perello, M, Escudero-López, E, Garcia-Cadenas, I, Esquirol, A, Martino, R, Jara-Bustamante, P, Ezquerra, P, Soria, JM, Iranzo, E, Moreno-Martinez, ME, Riba, M, Sierra, J, Alvarez-Fernández, C, Escribà-Garcia, L, Briones, J. HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma. BLOOD. 2025; 145(16)DOI:10.1182/blood.2024026758. PMID:39841453. IF:23.100(Q1/1D).
01/04/2025
[Translated article] Evaluation of the safety of medication-use systems in hospital emergency services
Otero, MJ, Díez, MA, Cartelle, HE, Hernández, SJ, Blanco, IM, Ucha, MS, Perrín, RS, Ramos, JR. [Translated article] Evaluation of the safety of medication-use systems in hospital emergency services. Farmacia Hospitalaria. 2025; 49(2)DOI:10.1016/j.farma.2024.10.015. PMID:39580345. IF:(Q/D).
01/04/2025
Evaluation of the safety of medication-use systems in hospital emergency services
Otero, MJ, Díez, MA, Cartelle, HE, Hernández, SJ, Blanco, IM, Ucha, MS, Perrín, RS, Ramos, JR. Evaluation of the safety of medication-use systems in hospital emergency services. Farmacia Hospitalaria. 2025; 49(2)DOI:10.1016/j.farma.2024.07.007. PMID:39181756. IF:(Q/D).
01/03/2025
Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach
Lobo-Prat, D, Sainz, L, Laiz, A, De Dios, A, Fontcuberta, L, Fernández, S, Masip, M, Riera, P, Pages-Puigdemont, N, Ros, S, Gomis-Pastor, M, Corominas, H. Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach. JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2025; 31(2)DOI:10.1111/jep.14132. PMID:39253893. IF:2.100(Q2/3D).
01/03/2025
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment
Redondo, S, Costa, M, Moreno-Martinez, ME, Arguello-Tomas, M, Riba, M, Aso, O, Iranzo, E, Esquirol, A, Sierra, J, Briones, J, Martino, R, Zapico, E, Garcia-Cadenas, I. Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 114(3)DOI:10.1111/ejh.14349. PMID:39545520. IF:2.300(Q2/5D).